.

 

The BRC-KT Grant Program is designed to move discoveries and inventions along the path to commercialization—with a view to attracting new investment, creating new neuroscience-based businesses, organizations and initiatives, and ultimately to improving neurological health outcomes for Nova Scotians and Canadians. It provides funding for proof-of-principle or pre-commercialization research projects, so that researchers who have reached that critical point in their progress from scientific discovery to usable technology are able to take the next step.

BRC-KT program provides funding to projects and initiatives that:

  • apply neuroscience research results to improving the health of Nova Scotians and Canadians
  • allow researchers to conduct proof-of-principle experiments and acquire necessary information—such as toxicology or pharmacokinetic data—from contract research organizations
  • enable researchers to assess the commercial viability of an innovation and/or enhance the value of their intellectual property
  • support technology transfer to accelerate commercialization
  • foster an entrepreneurial culture in the neuroscience research community
  • promote economic development through neuroscience research

 

Click here to view the 2016-2017 call for submissions
The deadline for applications for the this year's competition is Friday March 3rd, 2017.

For more information about submitting a proposal to the BRC-KT Grant Program, contact Eleanor Seaman-Bolton, This email address is being protected from spambots. You need JavaScript enabled to view it. (902) 494-4010.


BRC KT Grants award history:

In 2016, BRC KT grants were awarded to Drs. George Robertson, Alon Friedman, Shaun Boe, and Michael Schmidt. Read story.

In 2015, BRC KT grants were awarded to Drs. David Clarke, Gail Eskes, and George Robertson. Read story.

In 2014, the BRC awarded KT grants to three research teams. Read story.

In 2013, the BRC awarded the very first round of KT grants to three researchers, pictured above with Dr. Vic Rafuse. Left to right: Dr. Ying Zhang, Dr. Sultan Darvesh, Dr. Alan Fine. Read story.


 

 

 

 

 

Saturday the 27th. © 2017. All rights reserved.. Bridgewater Media Services